Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 2, 2023
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
[ Wed, Aug 02nd 2023
] - WOPRAI
Corinne Jenkins Upgraded (TGTX) to Hold and Decreased Target to $12 on, Aug 2nd, 2023
Corinne Jenkins of Goldman Sachs, Upgraded "TG Therapeutics, Inc." (TGTX) to Hold and Decreased Target from $16 to $12 on, Aug 2nd, 2023.
Corinne has made no other calls on TGTX in the last 4 months.
There are 3 other peers that have a rating on TGTX. Out of the 3 peers that are also analyzing TGTX, 0 agree with Corinne's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Corinne
- Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $41 on, Tuesday, August 1st, 2023
- Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $38 on, Tuesday, May 2nd, 2023
- Prakhar Agrawal of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $24 on, Monday, April 17th, 2023
